IP Library Granted Patent US 7,598,375
Granted Patent B2
US 7,598,375 · App. 11/500,378 · Granted Oct 6, 2009

Method of acylating maytansinol with chiral amino acids

Assignee: Millenium Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,598,375
App. No.
11/500,378
Granted
Oct 6, 2009
Kind
B2
Abstract

This invention provides a method for making maytansinoids having a chiral amino acid side chain, such as DM1 and DM4 that are used to treat cancer. According to this method, the side chain may be added with little epimerization of the amino acid chiral center.

Claims (37)

1. A method of making a compound of formula A:

where:

X is Cl or H, and

R is

R 1 is a naturally-occurring amino acid side chain;

R 2 is hydrogen or a C 1-6 alkyl group;

said method comprising:

(a) providing a mixture comprising

(i) a starting material which has a formula identical to formula A except that R is hydrogen,

(ii) a compound of formula 2:

(iii) a Lewis acid,

(iv) a non-nucleophilic base and

(v) an organic solvent;

(b) allowing the mixture of step (a) to react until some of the starting material is converted to the compound of formula A;

(c) removing crude compound of formula A from the mixture of step (b); and

(d) optionally purifying the compound of formula A obtained in step (c).

2. The method of claim 1 wherein the starting material is maytansinol.

3. The method of claim 2 where R 1 is a C 1-6 alkyl and R 2 is a C 1-6 alkyl.

4. The method of claim 3 wherein 2 is predominantly (S)-isomer.

5. The method of claim 4 wherein 2 is 3,4-dimethyl-oxazolidine-2,5-dione.

6. A method of making a compound of formula II:

wherein:

X is Cl or H;

R 1 is a naturally-occurring amino acid side chain;

R 2 is hydrogen, C 1-6 alkyl, aryl or aralkyl;

L is a C 2-6 alkylene chain having 0-2 substituents independently selected from the group consisting of halo, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 haloalkyl, and C 1-6 haloalkoxy;

R 3 is hydrogen or S—R 4 ; and

R 4 is C 1-6 alkyl, aryl, or aralkyl;

the method comprising:

(a) obtaining a compound of formula I:

 by a coupling reaction of 2 with maytansinol or its analogue where X=H, wherein the coupling reaction is performed in the presence of a Lewis acid, a non-nucleophilic base and an organic solvent;

(b) coupling the compound of formula I obtained from step (a) with R 5 O 2 C—L—S—S—R 4 , where R 5 is hydrogen or an activating group to provide the compound of formula II where R 3 is S—R 4 ; and

(c) optionally treating the compound of formula II obtained in step (b) with a reducing agent to provide a compound of formula II where R 3 is hydrogen.

7. The method of claim 6 where R 2 is hydrogen or C 1-6 alkyl and L is a C 2-3 alkylene chain having 0-2 substituents independently selected from C 1-6 alkyl.

8. The method of claim 7 where L is an alkylene chain substituted by 0-2 methyl groups.

9. The method of claim 8 where R 5 O 2 C—L—S—S—C 1-6 alkyl is:

10. The method of claim 9 wherein the compound of formula II obtained in step (b) is treated with a reducing agent to provide a compound of formula II where R 3 is hydrogen.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Feb 12, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
Reel/Frame 066553/0109 →
PATENT SECURITY AGREEMENT Recorded Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2016
From: CARROZZELLA, DARREN J.; HO, GUOJIE
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 039052/0966 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2016
From: MILLENNIUM PHARMACEUTICALS, INC.
To: IMMUNOGEN, INC.
Reel/Frame 039052/0987 →
ADDRESS CHANGE Recorded May 13, 2008
From: IMMUNOGEN, INC.
To: IMMUNOGEN, INC.
Reel/Frame 020930/0905 →
Continuity (2)
Provisional Application 6070669400 · Aug 9, 2005
Related Publication 20070037972A1 · Feb 15, 2007